First U.S. use of CRISPR directly targeting cancer to seek OK - STAT

First U.S. use of CRISPR directly targeting cancer to seek OK - STAT

First U.S. use of CRISPR to directly target cancer will seek go-ahead from regulators

By SHARON BEGLEY

CHRISTIANA CARE HEALTH SYSTEM

If approved, the first U.S. clinical trial testing CRISPR against cancer by altering tumor DNA in patients could begin recruiting participants next year.

READ MORE